医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

DSG, Inc. Accelerates Growth with Opening of New Office in Bangalore, India
DSG, Inc., leading provider of eClinical technology solutions, data management, professional services and customer support recently opened a new office in Bangalore, India, to accommodate rapid growth and better serve client needs. DSG's Bangalore office will complement its existing facility located in Noida, India. DSG Bangalore’s state-of-the-art facility will occupy a floor in the Prestige Shantiniketan building. The new office space will accommodate over 300 people and support the company’s growth strategy. In expanding its footprint, DSG adds expertise, scale, and breadth of services, adding staff from a highly skilled pool of manager-level employees bringing years of industry experience from some of the largest pharmaceutical companies and global Clinical Research Organizations.… 続きを読む
2017年01月20日 PM10:00
2017年01月20日
仁和集团与APR应用制药研究公司公布协议在中国市场销售治疗偏头痛创新药
APR 应用制药研究公司("APR"),一家瑞士的独立科学研发及拥有专利保护的保健产品公司,与仁和集团,一家中国领先的制药公司,今天宣布在中国、香港、澳门和台湾开始宣传、分销APR的获得专利的双氯芬酸粉口服液用以治疗偏头痛。… 続きを読む
2017年01月20日
武田连续第二年入选全球可持续发展最佳企业百强榜单
武田药品工业株式会社(Takeda Pharmaceutical Company Limited) [TOKYO:4502](简称“武田”)入选由《企业爵士》(Corporate Knights)评选的2017年全球可持续发展企业百强榜单(2017 Global 100 Most Sustainable Corporations in the World Index),公司对此感到十分自豪。这是武田连续第二年入围该榜单,其评选是基于14项关键业绩指标,包括能源生产力、创新能力、安全表现和领导多元化。… 続きを読む
2017年01月20日
InFo 124M – 瑞士生产的用于白内障手术的延伸焦深人工晶体
Swiss Advanced Vision公司(SAV-IOL SA - www.sav-iol.com)不断壮大其人工晶体(IOL)产品阵容,宣布上市一款新产品,该产品基于该公司于2016年1月首次上市的InFo系列。InFo晶体旨在白内障手术后替换晶状体,使患者恢复视力,免于佩戴眼镜,避免了不必要的视觉不良效应,并保全解像度。… 続きを読む
2017年01月20日
2017 Taiwan WHO Simulation Kicks off at NCKU with 240 Medical Students Sharing
National Cheng Kung University (NCKU) is currently hosting a special international conference organized by a group of medical students in Taiwan. 2017 Taiwan World Health Organization (WHO) Simulation, the first conference in Asia modeling the WHA (World Health Assembly), kicked off on January 18 with 240 students from over 20 countries including America, Finland, Japan, Korea, Sudan, India, and Indonesia.… 続きを読む